Clinical Trials Directory

Trials / Completed

CompletedNCT05758714

Effects of Transportation Choices on Commuter Health

Effects of Transportation Choices on Commuter Health (ETCH): Impacts of Modifiable Factors on Personal Exposures and Acute Health

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The primary project objective is to investigate how an individual's choices influence personal exposures to traffic-related air pollutants (TRAPs) and the corresponding acute health effects. TRAPs are a complex mixture of particulate and gaseous pollutants that vary considerably spatially and temporally. There is increasing evidence that TRAPs inflict a broad range of deleterious health effects in both health-compromised and healthy individuals, and it has been reported that traffic pollutants may cause up to half of all air pollution-related mortalities. Despite the burden from such widespread, involuntary exposures, few studies have examined the magnitude of personal exposures due to commuting exposures. Most commuters travel to and from work during two peak travel periods, which occur during weekday mornings and evenings. Public transportation, bicycling, and walking have been promoted as ways to reduce air pollution by reducing the vehicle fleet, yet few studies have examined how exposures are modified due to an intentional change in the time of commute or the subsequent health effects.

Detailed description

65 participants will be asked to modify the time of day that they commute to work to examine if changes in their time of departure can reduce air pollution exposures and lead to meaningful health benefits. Participants will be asked to commute to work during the morning rush hour for two consecutive days and then outside peak traffic times during a separate sampling period. During the two 48-hour sampling periods, real-time PM2.5, CO, CO2, NO2, O3, temperature, relative humidity, location, and noise will be measured. Passive personal monitors that can sequester more than 1500 chemicals will also be incorporated. These measurements will be complemented with assessments of four urinary biomarkers, urinary benzene, blood pressure, lung function, and pulmonary inflammation of the lower airways. Since TRAPs tend to be most concentrated during two relatively short periods of time, the study goal is to assess if adjustments in personal behavior can result in reduced exposures to TRAPs and lead to health benefits.

Conditions

Timeline

Start date
2023-02-06
Primary completion
2025-04-14
Completion
2025-04-24
First posted
2023-03-07
Last updated
2025-06-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05758714. Inclusion in this directory is not an endorsement.